Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Change in Receivables (2022 - 2025)

Historic Change in Receivables for Zentalis Pharmaceuticals (ZNTL) over the last 3 years, with Q1 2025 value amounting to -$5.0 million.

  • Zentalis Pharmaceuticals' Change in Receivables changed N/A to -$5.0 million in Q1 2025 from the same period last year, while for Dec 2024 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2024, which is N/A changed from last year.
  • Per Zentalis Pharmaceuticals' latest filing, its Change in Receivables stood at -$5.0 million for Q1 2025.
  • Over the past 5 years, Zentalis Pharmaceuticals' Change in Receivables peaked at $5.0 million during Q4 2024, and registered a low of -$5.0 million during Q1 2025.
  • For the 3-year period, Zentalis Pharmaceuticals' Change in Receivables averaged around $1333.3, with its median value being $4000.0 (2022).